Press release
Clot Management Devices Market Is Progressing Towards A Strong Growth By 2020
North America dominates the global market for clot management devices due to introduction of neurovascular embolectomy device. Asia is expected to show high growth rates in the next five years in global clot management devices market.
Request Sample Report@ https://www.persistencemarketresearch.com/samples/3338
China and India are expected to be the fastest growing clot management devices markets in Asia-Pacific region. Some of the key driving forces for clot management devices market in emerging countries are increasing investment in healthcare infrastructure, lack of prophylactic inferior vena cava filter and large pool of patients.
In recent times there is increased use of clot management devices due to rising prevalence of periphery artery disease. Increasing prevalence of coronary heart diseases and kidney diseases and increasing aging population are some of the key factors driving the growth for global clot management devices market. In addition, increasing healthcare awareness is also fuelling the growth of global clot management devices market. However, lack of trained physician and lack of reimbursements in developing countries are some of the major factors restraining the growth for the global clot management devices market. In addition, anticoagulant therapy is the first choice of treatment for deep vein thrombosis which is also inhibiting the growth of the global clot management device market.
Request Report for TOC @ https://www.persistencemarketresearch.com/toc/3338
Increasing innovation of clot management products would develop opportunity for global clot management devices market. However, complications in device handling could lead a challenge for global clot management devices market. The trend for global clot management devices market is combined use of catheter directed thrombolysis and percutaneous thrombectomy for the treatment of acute venous thrombosis. Some of the major companies operating in the global clot management devices market are Medtronic, Cook Medical, AngioDynamics, Rex Medical, Boston Scientific, Merit Medical Systems and Vascular Solutions.
About Us
Persistence Market Research (PMR) is a third-platform research firm. Our research model is a unique collaboration of data analytics and market research methodology to help businesses achieve optimal performance.To support companies in overcoming complex business challenges, we follow a multi-disciplinary approach. At PMR, we unite various data streams from multi-dimensional sources. By deploying real-time data collection, big data, and customer experience analytics, we deliver business intelligence for organizations of all sizes.
Contact Us
Persistence Market Research
305 Broadway
7th Floor, New York City,
NY 10007, United States,
USA – Canada Toll Free: 800-961-0353
Email: sales@persistencemarketresearch.com
Web: http://www.persistencemarketresearch.com
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Clot Management Devices Market Is Progressing Towards A Strong Growth By 2020 here
News-ID: 1077622 • Views: …
More Releases from Persistence Market Research Pvt.Ltd.
Dental Restoration Market Present Scenario and the Growth Prospects 2017 - 2025
The term dental restoration covers an integrated management of oral health and restoring the oral health to a functional and esthetic state. The American Dental Association has not considered restorative dentist as a separate specialty though the dentists are able to perform man of these procedures without any additional course or certification. The dental restoration procedures depend on how difficult the procedure is and what the professional feels comfortable with.…
Mobile Air Transfer Systems Market Trends and Key Developments 2017 - 2025
Mobile air transfer system is the system used in hospitals and other medical centers that helps to reduce patient handling injury. The system provides patients with simple and comfortable transfer experience along with significantly reducing the cumulative handling effect of thousands of pounds of patients’ weight while routine transfers. To ensure the safety of hundreds of millions of people suffering from health care associated infections and abnormalities mobile air transfer…
Orthopedic Veterinary Implants Market is projected to reach US$ 3,500 Mn by 2026
Arthritis is a common disorder which has been recently seen spreading its roots dogs. At present, this diseases is treated with the help of orthopedic veterinary implants. The global orthopedic veterinary implants market has witnessed a substantial surge in the last couple years owing to the rise in pet adoption and their orthopedic surgeries. Majority of the population, especially in the developed regions, own pets such as cats or dogs.…
Prepackaged Medical Kits and Trays Market is anticipated to Register a CAGR of 8 …
There has been a Herculean shift in the healthcare industry towards a reformed model and significant rise in investments worldwide is intended to improve various facilities and services across the healthcare industry. The concept of value-based pricing of pharmaceuticals has gained momentum in the last few years and a majority of the OECD countries have adopted this model. This shift has been a crucial component for the revenue growth of…
More Releases for Clot
Top Factor Driving Clot Management Devices Market Growth in 2025: Rising Hospita …
How Big Is the Clot Management Devices Market Expected to Be, and What Will Its Growth Rate Be?
The market for clot management devices has seen significant growth in recent years. The market is expected to expand from a value of $1.72 billion in 2024 to approximately $1.83 billion in 2025, representing a compound annual growth rate (CAGR) of 6.4%. This growth during the historical period can be linked to factors…
Clot Management Devices Market Report 2024 - Clot Management Devices Market Shar …
"The Business Research Company recently released a comprehensive report on the Global Clot Management Devices Market Size and Trends Analysis with Forecast 2024-2033. This latest market research report offers a wealth of valuable insights and data, including global market size, regional shares, and competitor market share. Additionally, it covers current trends, future opportunities, and essential data for success in the industry.
Ready to Dive into Something Exciting? Get Your Free Exclusive…
Clot Management Devices Market Is Driven By Clot Management Devices In Various I …
The Clot Management Devices Market is experiencing significant growth and innovation, primarily due to the increasing incidence of thromboembolic diseases and the rising awareness of the importance of efficient clot removal techniques. Thromboembolic conditions, such as deep vein thrombosis (DVT) and pulmonary embolism, pose substantial risks to patient health and can result in life-threatening situations. Clot management devices, which include catheters, aspiration systems, and mechanical thrombectomy devices, play a crucial…
Blood Clot Retrieval Devices Market - From Clot to Flow: Blood Clot Retrieval De …
Newark, New Castle, USA - The latest report from Growth Plus Reports analyzes the production, potential applications, demand, major manufacturers, and SWOT analysis of the global Blood Clot Retrieval Devices Market.
Blood Clot Retrieval Devices Market: https://www.growthplusreports.com/report/blood-clot-retrieval-devices-market/9174
The Blood Clot Retrieval Devices Market Report assists in determining the optimum distribution methods for certain products as well as possible markets for future product launches. The report also analyses the purchase and supply trends…
Rivaroxaban Market Insights – Stop the Clot
Rivaroxaban is a Non-Vitamin K Antagonist Oral Anticoagulants (NOAC) that is marketed as Xarelto. Anticoagulant medicines are potent therapeutic agents used in the prevention or treatment of serious illnesses and potentially life-threatening conditions associated with blood coagulation. Rivaroxaban was discovered by Bayer and is being jointly developed with Janssen Research & Development, LLC. Xarelto is approved for indications such as stroke prevention in non-valvular atrial fibrillation, pulmonary embolism, deep vein…
Clot Management Devices Market: Global Markets & Advanced Technologies
Global Clot Management Devices Market: Overview
According to an article published in the Journal of Thrombosis and Haemostasis, the awareness about venous thromboembolism (VTE) remains alarmingly low. What makes this scenario more concerning is that nearly 10 million VTE cases are estimated to occur every year across the world making this condition among the leading causes of disability worldwide. The International Society on Thrombosis and Haemostasis, Inc. states that while…
